Journal Article
. 2016 Jan;12(1).
doi: 10.2217/whe.15.99.

Breast cancer subtypes: morphologic and biologic characterization

Shahla Masood 1 
Affiliations
  • PMID: 26756229
  •     83 References
  •     10 citations

Abstract

Advances in basic science, technology and translational research have created a revolution in breast cancer diagnosis and therapy. Researchers' discoveries of genes defining variability in response to therapy and heterogeneity in clinical presentations and tumor biology are the foundation of the path to personalized medicine. The success of personalized breast cancer care depends on access to pertinent clinical information and risk factors, optimal imaging findings, well-established morphologic features, and traditional and contemporary prognostic/predictive testing. The integration of these entities provides an opportunity to identify patients who can benefit from specific therapies, and demonstrates the link between breast cancer subtypes and their association with different tumor biology. It is critical to recognize specific types of breast cancer in individual patients and design optimal personalized therapy. This article will highlight the roles of morphologic features and established tumor biomarkers on patient outcome.

Keywords: breast cancer subtypes; molecular characterization; personalized medicine.

Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications.
L Pedersen, S Holck, +2 authors, H T Mouridsen.
Breast Cancer Res Treat, 1989 Oct 01; 14(1). PMID: 2605345
Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.
Magali Lacroix-Triki, Paula H Suarez, +7 authors, Jorge S Reis-Filho.
J Pathol, 2010 Sep 04; 222(3). PMID: 20815046
Lipid-rich carcinoma of the breast. A clinicopathological study of 49 cases.
Peng Shi, Mingming Wang, Qinghui Zhang, Jingzhong Sun.
Tumori, 2008 Aug 19; 94(3). PMID: 18705401
Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type.
Britta Weigelt, Felipe C Geyer, +3 authors, Jorge S Reis-Filho.
Mod Pathol, 2009 Jul 28; 22(11). PMID: 19633645
Molecular classification of breast tumors: toward improved diagnostics and treatments.
Therese Sørlie.
Methods Mol Biol, 2006 Dec 19; 360. PMID: 17172726
Review.
Invasive micropapillary carcinoma of the breast is associated with chromosome 8 abnormalities detected by comparative genomic hybridization.
Ann D Thor, Clarence Eng, +6 authors, Frederic M Waldman.
Hum Pathol, 2002 Aug 02; 33(6). PMID: 12152162
Infiltrating cribriform carcinoma of the breast. A clinico-pathologic and immunohistochemical study of 5 cases.
F Marzullo, F A Zito, +5 authors, F Colonna.
Eur J Gynaecol Oncol, 1996 Jan 01; 17(3). PMID: 8780923
Glycogen-rich clear cell carcinoma of the breast: a light and electron microscopic study.
M T Hull, J B Priest, +2 authors, L J McCarthy.
Cancer, 1981 Nov 01; 48(9). PMID: 6271388
Triple-negative breast cancer.
William D Foulkes, Ian E Smith, Jorge S Reis-Filho.
N Engl J Med, 2010 Nov 12; 363(20). PMID: 21067385
Highly Cited. Review.
The effect of high dehydroepiandrosterone sulfate levels on tamoxifen blockade and breast cancer progression.
Kristine Calhoun, Rodney Pommier, +2 authors, SuEllen Toth-Fejel.
Am J Surg, 2003 May 03; 185(5). PMID: 12727558
Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer.
Gary C Hon, R David Hawkins, +14 authors, Bing Ren.
Genome Res, 2011 Dec 14; 22(2). PMID: 22156296    Free PMC article.
Highly Cited.
Microarray analysis and tumor classification.
John Quackenbush.
N Engl J Med, 2006 Jun 09; 354(23). PMID: 16760446
Highly Cited. Review.
Multifocal invasive ductal breast cancer with osteoclast-like giant cells: a case report.
Georg Richter, Christoph Uleer, Thomas Noesselt.
J Med Case Rep, 2011 Mar 01; 5. PMID: 21352587    Free PMC article.
Tubular carcinoma of the breast: mammographic and sonographic features.
D G Sheppard, G J Whitman, +3 authors, C B Stelling.
AJR Am J Roentgenol, 2000 Jan 11; 174(1). PMID: 10628489
The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study.
Nicole N Esposito, Mamatha Chivukula, David J Dabbs.
Mod Pathol, 2006 Dec 05; 20(1). PMID: 17143261
The pathological and biological nature of screen-detected breast carcinomas: a morphological and immunohistochemical study.
W K Cowan, P Kelly, +7 authors, B Angus.
J Pathol, 1997 May 01; 182(1). PMID: 9227339
Solid neuroendocrine carcinomas of the breast: metastases or primary tumors?
Christiane Richter-Ehrenstein, Juliane Arndt, +5 authors, Aurelia Noske.
Breast Cancer Res Treat, 2010 Sep 28; 124(2). PMID: 20872069
Tubular carcinoma of the breast: mammographic, sonographic, clinical and pathologic findings.
Işil Günhan-Bilgen, Ayşenur Oktay.
Eur J Radiol, 2006 Sep 22; 61(1). PMID: 16987629
Mammographic features of pure mucinous carcinoma of the breast with pathological correlation.
D N Goodman, O Boutross-Tadross, R A Jong.
Can Assoc Radiol J, 1995 Aug 01; 46(4). PMID: 7543806
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma.
Torsten O Nielsen, Forrest D Hsu, +13 authors, Charles M Perou.
Clin Cancer Res, 2004 Aug 26; 10(16). PMID: 15328174
Highly Cited.
The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications.
Emiliano Honrado, Javier Benítez, José Palacios.
Mod Pathol, 2005 Jun 04; 18(10). PMID: 15933754
Review.
A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Salomone Di Saverio, Juan Gutierrez, Eli Avisar.
Breast Cancer Res Treat, 2007 Nov 21; 111(3). PMID: 18026874
Clinical and pathologic aspects of basal-like breast cancers.
Oluwole Fadare, Fattaneh A Tavassoli.
Nat Clin Pract Oncol, 2008 Jan 24; 5(3). PMID: 18212769
Review.
Relationship between breast histopathology and family history of breast cancer.
E B Claus, N Risch, W D Thompson, D Carter.
Cancer, 1993 Jan 01; 71(1). PMID: 8380113
Sonographic evaluation of infiltrating lobular carcinoma.
R S Butler, L A Venta, +3 authors, E Rubin.
AJR Am J Roentgenol, 1999 Feb 04; 172(2). PMID: 9930776
Molecular portraits of human breast tumours.
C M Perou, T Sørlie, +15 authors, D Botstein.
Nature, 2000 Aug 30; 406(6797). PMID: 10963602
Highly Cited.
Tubular carcinoma of the breast. Predicting axillary nodal metastases and recurrence.
D J Winchester, A A Sahin, S L Tucker, S E Singletary.
Ann Surg, 1996 Mar 01; 223(3). PMID: 8604915    Free PMC article.
Review.
Mammary carcinoma with osteoclast-like giant cells. Additional observations on six cases.
R Holland, U J van Haelst.
Cancer, 1984 May 01; 53(9). PMID: 6704923
Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
William F Anderson, Kenneth C Chu, Shine Chang, Mark E Sherman.
Cancer Epidemiol Biomarkers Prev, 2004 Jul 13; 13(7). PMID: 15247123
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.
Cristina Tognon, Stevan R Knezevich, +9 authors, Poul H B Sorensen.
Cancer Cell, 2002 Nov 27; 2(5). PMID: 12450792
Highly Cited.
Small cell carcinoma of the breast: a clinicopathologic and immunohistochemical study of nine patients.
S J Shin, R A DeLellis, L Ying, P P Rosen.
Am J Surg Pathol, 2000 Sep 08; 24(9). PMID: 10976697
Apocrine mammary carcinoma. A clinicopathologic study of 72 cases.
A D Abati, M Kimmel, P P Rosen.
Am J Clin Pathol, 1990 Oct 01; 94(4). PMID: 2171320
Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma.
H Nassar, T Wallis, +3 authors, D Visscher.
Mod Pathol, 2001 Sep 15; 14(9). PMID: 11557778
Goodbye to "fibrocystic disease".
R V Hutter.
N Engl J Med, 1985 Jan 17; 312(3). PMID: 3965938
Deconstructing the molecular portraits of breast cancer.
Aleix Prat, Charles M Perou.
Mol Oncol, 2010 Dec 15; 5(1). PMID: 21147047    Free PMC article.
Highly Cited. Review.
Repeated observation of breast tumor subtypes in independent gene expression data sets.
Therese Sorlie, Robert Tibshirani, +13 authors, David Botstein.
Proc Natl Acad Sci U S A, 2003 Jun 28; 100(14). PMID: 12829800    Free PMC article.
Highly Cited.
Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.
Luisella Righi, Anna Sapino, +2 authors, Gianni Bussolati.
Semin Diagn Pathol, 2010 Mar 24; 27(1). PMID: 20306832
Systemic treatment strategies for triple-negative breast cancer.
Budhi Singh Yadav, Suresh C Sharma, Priyanka Chanana, Swaty Jhamb.
World J Clin Oncol, 2014 May 16; 5(2). PMID: 24829859    Free PMC article.
Review.
Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics.
Junichi Kurebayashi.
Breast Cancer, 2009 May 02; 16(4). PMID: 19408071
p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components.
Huang-Chun Lien, Chung-Wu Lin, +3 authors, Chiun-Sheng Huang.
J Pathol, 2004 Sep 18; 204(2). PMID: 15376261
Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
M R Wick, T J Lillemoe, +3 authors, D T Kiang.
Hum Pathol, 1989 Mar 01; 20(3). PMID: 2542151
Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas.
P T Simpson, J S Reis-Filho, +15 authors, S R Lakhani.
J Pathol, 2008 May 14; 215(3). PMID: 18473330
Fine needle aspiration cytology of invasive cribriform carcinoma of the breast with osteoclastlike giant cells: a case report.
W K Ng.
Acta Cytol, 2001 Aug 02; 45(4). PMID: 11480724
Expression profiling predicts outcome in breast cancer.
Laura J van 't Veer, Hongyue Dai, +4 authors, Stephen H Friend.
Breast Cancer Res, 2003 Feb 01; 5(1). PMID: 12559048    Free PMC article.
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade.
Britta Weigelt, Frederick L Baehner, Jorge S Reis-Filho.
J Pathol, 2009 Nov 21; 220(2). PMID: 19927298
Highly Cited. Review.
Expression of the neuroendocrine phenotype in carcinomas of the breast.
A Sapino, L Righi, +3 authors, G Bussolati.
Semin Diagn Pathol, 2000 Jun 06; 17(2). PMID: 10839613
Review.
Acantholytic squamous cell carcinoma of the oral cavity: a more aggressive entity?
Cyrus J Kerawala.
Br J Oral Maxillofac Surg, 2008 Jun 21; 47(2). PMID: 18565630
Invasive micropapillary carcinoma of the breast. A new special type of invasive mammary carcinoma.
S Luna-Moré, B Gonzalez, +2 authors, C Luna.
Pathol Res Pract, 1994 Aug 01; 190(7). PMID: 7808965
Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.
Andrea L Kasinski, Frank J Slack.
Nat Rev Cancer, 2011 Nov 25; 11(12). PMID: 22113163    Free PMC article.
Highly Cited. Review.
Secretory carcinoma of the breast.
F A Tavassoli, H J Norris.
Cancer, 1980 May 01; 45(9). PMID: 6445777
Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients.
H A Oberman.
Am J Surg Pathol, 1987 Dec 01; 11(12). PMID: 2825549
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.
Soonmyung Paik, Gong Tang, +11 authors, Norman Wolmark.
J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680
Highly Cited.
Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.
Emad A Rakha, Maysa E El-Sayed, +9 authors, Ian O Ellis.
Eur J Cancer, 2007 Nov 24; 44(1). PMID: 18035533
Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR.
Rohit Bhargava, Sushil Beriwal, Joan M Striebel, David J Dabbs.
Appl Immunohistochem Mol Morphol, 2009 Oct 06; 18(2). PMID: 19801938
Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum.
Marick Laé, Paul Fréneaux, +3 authors, Anne Vincent-Salomon.
Mod Pathol, 2008 Nov 18; 22(2). PMID: 19011601
Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction.
L Rønnov-Jessen, O W Petersen, M J Bissell.
Physiol Rev, 1996 Jan 01; 76(1). PMID: 8592733
Highly Cited. Review.
Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
Sarah A Thurman, Stuart J Schnitt, +4 authors, Abram Recht.
Int J Radiat Oncol Biol Phys, 2004 Apr 20; 59(1). PMID: 15093911
Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women.
Early Breast Cancer Trialists' Collaborative Group.
N Engl J Med, 1988 Dec 29; 319(26). PMID: 3205265
Highly Cited.
Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: matched case-control study.
Jeong Il Yu, Doo Ho Choi, +6 authors, Suk Jin Nam.
Breast, 2010 Mar 23; 19(3). PMID: 20304650
Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers.
Sebastian Leibl, Margit Gogg-Kammerer, +2 authors, Farid Moinfar.
Am J Surg Pathol, 2005 Feb 24; 29(3). PMID: 15725803
Immunohistochemical and clinicopathologic characteristics of invasive ductal carcinoma of breast with micropapillary carcinoma component.
Mi-Jung Kim, Gyungyub Gong, +2 authors, Jae Y Ro.
Arch Pathol Lab Med, 2005 Oct 04; 129(10). PMID: 16196516
Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes.
Massimo Cristofanilli, Ana Gonzalez-Angulo, +9 authors, Gabriel N Hortobagyi.
J Clin Oncol, 2004 Dec 31; 23(1). PMID: 15625359
Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast.
Emad A Rakha, Arjun Patel, +5 authors, Ian O Ellis.
Am J Surg Pathol, 2010 Sep 28; 34(10). PMID: 20871222
Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands.
Marieke W J Louwman, Martine Vriezen, +5 authors, Jan Willem W Coebergh.
Int J Cancer, 2007 Mar 03; 121(1). PMID: 17330844
On the diagnosis and treatment of breast cancer.
M S Fox.
JAMA, 1979 Feb 02; 241(5). PMID: 759664
Mucinous carcinoma of the breast: recurrence 30 years after mastectomy.
D Scharnhorst, M Huntrakoon.
South Med J, 1988 May 01; 81(5). PMID: 2835821
p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer.
A Ribeiro-Silva, L N Z Ramalho, +3 authors, S Zucoloto.
Histopathology, 2005 Oct 26; 47(5). PMID: 16241993
Taxonomy of breast cancer based on normal cell phenotype predicts outcome.
Sandro Santagata, Ankita Thakkar, +13 authors, Tan A Ince.
J Clin Invest, 2014 Jan 28; 124(2). PMID: 24463450    Free PMC article.
Highly Cited.
Patterns of metastatic breast cancer in relation to histological type.
S Jain, C Fisher, +2 authors, R D Rubens.
Eur J Cancer, 1993 Jan 01; 29A(15). PMID: 8297656
The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies.
Kalliopi P Siziopikou, Melody Cobleigh.
Breast, 2006 Nov 14; 16(1). PMID: 17097880
Histological types of breast cancer: how special are they?
Britta Weigelt, Felipe C Geyer, Jorge S Reis-Filho.
Mol Oncol, 2010 May 11; 4(3). PMID: 20452298    Free PMC article.
Highly Cited. Review.
Medullary carcinoma of the breast, prognostic importance of characteristic histopathological features evaluated in a multivariate Cox analysis.
L Pedersen, S Holck, +2 authors, H T Mouridsen.
Eur J Cancer, 1994 Jan 01; 30A(12). PMID: 7880608
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
Lancet, 2005 May 17; 365(9472). PMID: 15894097
Highly Cited.
Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer.
L Pedersen, K Zedeler, +2 authors, H T Mouridsen.
Eur J Cancer, 1995 Dec 01; 31A(13-14). PMID: 8652258
Invasive cribriform carcinoma with extensive microcalcifications in the male breast.
Rieko Nishimura, Shozo Ohsumi, +3 authors, Shigemitsu Takashima.
Breast Cancer, 2005 Apr 29; 12(2). PMID: 15858447
Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.
L G Fulford, D F Easton, +4 authors, A Hanby.
Histopathology, 2006 Jul 18; 49(1). PMID: 16842243
Gene signatures of breast cancer progression and metastasis.
David I Rodenhiser, Joseph D Andrews, Theodore A Vandenberg, Ann F Chambers.
Breast Cancer Res, 2011 Feb 25; 13(1). PMID: 21345283    Free PMC article.
Review.
The "Rosen Triad": tubular carcinoma, lobular carcinoma in situ, and columnar cell lesions.
Suzanne M Brandt, Gloria Q Young, Syed A Hoda.
Adv Anat Pathol, 2008 Apr 25; 15(3). PMID: 18434766
Review.
Small cell neuroendocrine carcinoma of the breast: a report of three cases and review of the literature.
T Adegbola, C E Connolly, G Mortimer.
J Clin Pathol, 2005 Jun 25; 58(7). PMID: 15976350    Free PMC article.
Review.
Invasive micropapillary carcinoma of the breast: mammographic, sonographic, and MRI features.
Beatriz Adrada, Elsa Arribas, Michael Gilcrease, Wei Tse Yang.
AJR Am J Roentgenol, 2009 Jun 23; 193(1). PMID: 19542384
Review.
How basal are triple-negative breast cancers?
François Bertucci, Pascal Finetti, +4 authors, Daniel Birnbaum.
Int J Cancer, 2008 Apr 10; 123(1). PMID: 18398844
Highly Cited.
Metaplastic carcinomas of the breast. III. Carcinosarcoma.
E S Wargotz, H J Norris.
Cancer, 1989 Oct 01; 64(7). PMID: 2776108
Glycogen-rich clear cell carcinomas of the breast. A clinicopathologic and ultrastructural study.
M T Hull, K A Warfel.
Am J Surg Pathol, 1986 Aug 01; 10(8). PMID: 3017138
Moving toward appropriateness of breast cancer care: a balanced act to redefine the scope of standard of care.
Shahla Masood.
Womens Health (Lond), 2016 Feb 24; 12(2). PMID: 26901376    Free PMC article.
Profile of palbociclib in the treatment of metastatic breast cancer.
Moataz Ehab, Mohamad Elbaz.
Breast Cancer (Dove Med Press), 2016 Jun 09; 8. PMID: 27274308    Free PMC article.
Review.
Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
Charles Johannessen, Line Moi, +4 authors, Lill-Tove Busund.
PLoS One, 2017 Oct 27; 12(10). PMID: 29073169    Free PMC article.
Relationships between Reproductive Risk Factors for Breast Cancer and Tumor Molecular Subtypes
Nahid Nafissi, Maryam Faraji, +4 authors, Seyed Hamzeh Mousavie.
Asian Pac J Cancer Prev, 2018 Jul 28; 19(7). PMID: 30049185    Free PMC article.
Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer.
Natascha Stergiou, Johannes Nagel, +8 authors, Edgar Schmitt.
Int J Med Sci, 2019 Oct 08; 16(9). PMID: 31588183    Free PMC article.
A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.
Mustafa I Jaber, Bing Song, +5 authors, Christopher W Szeto.
Breast Cancer Res, 2020 Jan 30; 22(1). PMID: 31992350    Free PMC article.
TFAP2C regulates carbonic anhydrase XII in human breast cancer.
Christopher M Franke, Vivian W Gu, +4 authors, Mikhail V Kulak.
Oncogene, 2019 Oct 23; 39(6). PMID: 31636386
RILPL2 regulates breast cancer proliferation, metastasis, and chemoresistance via the TUBB3/PTEN pathway.
Guanglei Chen, Lisha Sun, +3 authors, Weiguang Liu.
Am J Cancer Res, 2019 Sep 10; 9(8). PMID: 31497344    Free PMC article.
Deep learning-enabled breast cancer hormonal receptor status determination from base-level H&E stains.
Nikhil Naik, Ali Madani, +5 authors, Richard Socher.
Nat Commun, 2020 Nov 18; 11(1). PMID: 33199723    Free PMC article.
Application of digital mammography-based radiomics in the differentiation of benign and malignant round-like breast tumors and the prediction of molecular subtypes.
Lanyun Wang, Wenjun Yang, +6 authors, Bin Song.
Gland Surg, 2021 Jan 16; 9(6). PMID: 33447551    Free PMC article.